Browsing by Author "Erçolak, Vehbi"

Now showing items 1-2 of 2

The effect of tumor sideness and mutational status on first line treatment response and survival in the patients with metastatic colorectal cancer

Eser, Kadir; Sezer, Emel Yaman; Öztürk, Banu; Onder, Arif Hakan; Erçolak, Vehbi; Oruç, Zeynep (Akademi Doktorlar Yayınevi, 2020)

RAS and BRAF mutation and primary tumour sideness are prognostic and predictive factors in metastatic colorectal cancer (mCRC). We aimed to investigate RAS-BRAF mutation rates and responses to biologic agents the effects ...
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma

Paydaş, Semra; Laçin, Şahin; Doğan, Mutlu; Barışta, İbrahim; Yıldız, Birol; Seydaoğlu, Gülşah; Civriz, Sinem; Kaplan, Muhammed Ali; Yağcı, Münci; Gürkan, Emel; Erçolak, Vehbi (Pergamon-Elsevier Science LTD, 2021)

The aim of this study is to validate the IPS-3 scoring system as a prognostic indicator in 1012 patients with advanced stage classical Hodgkin Lymphoma (cHL) treated by doxorubicin, bleomycin, vinblastine, dacarbazine ...